Fox Chase Cancer Center Welcomes Dr. Peter A. McCue

Dr McCue
Fox Chase Cancer Center is pleased to announce the hiring of Peter A. McCue, MD, as a Professor in the Department of Pathology.

PHILADELPHIA (June 27, 2023)—Fox Chase Cancer Center is pleased to announce the hiring of Peter A. McCue, MD, as a Professor in the Department of Pathology.

McCue has over 40 years of experience as a pathologist, the last 35 in a variety of roles at Thomas Jefferson University and Thomas Jefferson University Hospital. Some of these positions include Director of Surgical Pathology; Director of Anatomic Pathology; Director of Resident Training, Department of Pathology; and Vice Chair for Clinical Affairs, Department of Pathology.

McCue received his medical degree from the Mount Sinai School of Medicine and completed his internship and residency at New York-Presbyterian Hospital. Some of his research interests include the pathobiology of genitourinary tumors, diabetic renal disease, and the pathobiology of prostate cancer. McCue has published nearly 200 scholarly articles and book chapters.

He is a member of several academic and professional societies, including the International Academy of Pathology, the College of American Pathologists, and the American Association of Pathologists.

McCue began his tenure at Fox Chase on March 27.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text